Related Experiment Video
Updated: Sep 1, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Fibromodulin Ablation Exacerbates the Severity of Acute Colitis
Marianna Halasi1, Mor Grinstein2, Avner Adini3
1Department of Surgery, Center for Engineering in Medicine & Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Fibromodulin (FMOD) depletion exacerbates acute colitis in mice by damaging the epithelial barrier and increasing inflammation. Higher FMOD levels may protect against colitis severity in light-skinned populations.
Area of Science:
- Immunology
- Gastroenterology
- Dermatology
Background:
- Pigment production is linked to disease protection.
- European descendants have higher rates of inflammatory diseases like ulcerative colitis (UC).
Purpose of the Study:
- To investigate the role of fibromodulin (FMOD) in dextran sulfate sodium (DSS)-induced acute colitis.
- To determine if FMOD levels correlate with colitis severity in a mouse model.
Main Methods:
- Examined the effect of FMOD depletion on colitis severity in a mouse model.
- Assessed clinical symptoms and histopathological changes.
- Analyzed the expression of tight junction proteins and immune cell populations.
Main Results:
- Mice with high FMOD levels showed less severe acute colitis compared to FMOD-deficient mice.
- FMOD depletion impaired tight junction proteins, leading to epithelial barrier destruction.
- Absence of FMOD resulted in increased inflammation, activated T cells, plasmacytoid dendritic cells (pDCs), and type I interferon (IFN) production.
Conclusions:
- Fibromodulin (FMOD) plays a protective role in acute colitis.
- FMOD depletion exacerbates colitis by compromising the epithelial barrier and promoting inflammation.
- FMOD may serve as a biomarker for UC severity in light-skinned individuals of European descent.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...